Few and contrasting data are available in the literature concerning the levels of various cytokines in blister fluid (BF) and in the serum of patients affected with bullous pemphigoid (BP). Using commercially available ELISA kits, this study reports the levels of 11 cytokines detected both in BF and
Efficacy of interferon-γ in patients with refractory bullous pemphigoid
✍ Scribed by Takekuni NAKAMA; Norito ISHII; Fumitake ONO; Takahiro HAMADA; Shinichiro YASUMOTO; Takashi HASHIMOTO
- Book ID
- 108576339
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- French
- Weight
- 147 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0385-2407
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Bullous pemphigoid (BP) is a blistering skin disease in which the patient develops autoantibodies to the epidermal basement membrane zone. Using postembedding immunogold electron microscopy, we previously demonstrated that autoantibodies against the 230-kDa BP antigen (BPAG1) bind to the intracellul
## Background: Bullous pemphigoid (bp), linear iga bullous dermatosis (labd) and cicatricial pemphigoid (cp) are clinically distinct autoimmune bullous skin diseases characterized by autoantibodies against components of the epidermal basement membrane. like most patients with bp, a significant subg